Sept 15 (Reuters) - Teva Pharmaceutical Industries Ltd
said on Thursday it was collaborating with Intel Corp
to develop a wearable technology platform to track the
progression of disease in patients with Huntington's, a fatal
degenerative disorder.
Read more
No comments:
Post a Comment